TMS CoTSE:4891 -0.96%32 FCF Yield % is -11.18 as of Jul. 09, 2026. GuruFocus rates TSE:4891 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,407 Biotechnology companies, TMS Co ranks worse than 54.16% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, TMS Co's Trailing 12-Month Free Cash Flow is 円-524.60 Mil, and Market Cap is 円4,693.27 Mil. Therefore, TMS Co's FCF Yield % for today is -11.18%.
The historical rank and industry rank for TMS Co's FCF Yield % or its related term are showing as below:
TSE:4891'
s FCF Yield % Range Over the Past 10 Years
Min: -11.18 Med: 0 Max: 0
Current: -11.18
TSE:4891's FCF Yield % is ranked worse than 54.16% of 1407
companies
in the Biotechnology industry
Industry Median: -9.4
vs TSE:4891: -11.18
TMS Co's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.
TMS Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
TMS Co FCF Yield % Related Terms
TMS Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for TMS Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4891 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, TMS Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMS Co FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TMS Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where TMS Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMS Co (TSE:4891) has a FCF Yield % of -11.18 as of Jul. 09, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on TMS Co and its competitors. According to the industry distribution chart, TMS Co ranks #762 out of 1407 companies in the Biotechnology industry, placing it in the top 54.2%.
Is TMS Co's FCF Yield % too high?
TMS Co's current FCF Yield % is -11.18. Based on the distribution chart, TMS Co ranks #762 out of 1407 companies in the Biotechnology industry, which is below the industry midpoint. Overall, TMS Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does TMS Co's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TMS Co ranks #762 out of 1407 companies for FCF Yield %. This places TMS Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on TMS Co and its competitors. TMS Co's current FCF Yield % is -11.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMS Co stock overvalued right now?
TMS Co (TSE:4891) has a current FCF Yield % of -11.18. The current FCF Yield % is -11.18. TMS Co's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For TMS Co (TSE:4891), the current FCF Yield % is -11.18 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
32GF Score
Get the complete analysis for TSE:4891
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4891 has been successfully added to your 
